Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQQ7S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,734
Award facts
- Contract value 100% obligated
- $18,734.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,734.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with an ultimate completion date of December 16, 2025. This non-set-aside contract was competitively awarded on November 24, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. Enhertu (fam-trastuzumab deruxtecan) is a specialized oncology pharmaceutical, reflecting the Defense Logistics Agency's Medical Supply Chain mission to provide critical medications to military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQQ7S?
SPE2DR26FQQ7S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FQQ7S worth?
The government has obligated $18,734 on SPE2DR26FQQ7S.
Is contract SPE2DR26FQQ7S an order under another contract?
Yes. SPE2DR26FQQ7S is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ7S competed?
The extent of competition for SPE2DR26FQQ7S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award